INDICATIONS AND CLINICAL USE. Adults. Major Depressive Disorder. CYMBALTA (duloxetine hydrochloride) is indicated for the symptomatic
Duloxetine (Cymbalta). PEFC Approved: April 2024. Indications The. PEFC acknowledges that there are off-label indications for use that have supporting.
Cymbalta is indicated for the management of fibromyalgia (FM) [see Clinical Studies (14.4)]. 1.5. Chronic Musculoskeletal Pain. Cymbalta is indicated for the
INDICATIONS AND CLINICAL USE. Adults. Major Depressive Disorder. CYMBALTA (duloxetine hydrochloride) is indicated for the symptomatic
Indications and Important Safety Information About Cymbalta. Indications. Cymbalta is approved to treat major depressive disorder and generalized anxiety
Cymbalta (duloxetine) is used to treat major depressive disorder, general anxiety disorder and fibromyalgia. Includes Cymbalta side effects, interactions and indications.
Therapeutic Indications Of Cymbalta 60 Mg Capsules. Cymbalta is used to treat: Major depressive disorder (depression); Diabetic peripheral neuropathic pain
Cymbalta is indicated for the treatment of major depressive disorder (MDD). Cymbalta is indicated for the treatment of generalized anxiety disorder (GAD).
INDICATIONS AND CLINICAL USE. Adults. Major Depressive Disorder. CYMBALTA (duloxetine hydrochloride) is indicated for the symptomatic
Comments